Le Lézard
Classified in: Health
Subjects: LAW, VET, DEI

The Driscoll Firm Secures $299 Million Judgment for Families of U.S. Service Members Injured and Killed in Iraq


WASHINGTON, Aug. 16, 2022 /PRNewswire/ -- The team at The Driscoll Firm is proud to announce that they have secured a $299 million judgment against the Islamic Republic of Iran on behalf of families of U.S. service members wounded or killed in terrorist attacks in Iraq. The Driscoll Firm is committed to fighting for the rights of servicemembers and military families in all branches of the armed forces. We are proud to help them seek the answers, compensation, and justice they deserve. This judgment is a historic victory for these families, and we are honored to represent them.

From 2005 to 2008, 17 members of the U.S. military were injured or killed in fifteen separate terrorist attacks in Iraq. The Driscoll Firm brought the federal civil lawsuit, Pennington v. Islamic Republic of Iran, on behalf of servicemembers who were injured and the estates and families of those killed.

The plaintiffs successfully sought damages for economic and psychological injuries under the terrorism exception to the Foreign Sovereign Immunities Act (FSIA). The defendant, as expected, did not appear in court, leading The Driscoll Firm to move for a default judgment on behalf of the plaintiffs, which was granted by U.S. District Judge James E. Boasberg.

The lawsuit claimed that EFPs (explosively formed penetrators) were used in the attacks. Commonly referred to as "roadside bombs," these weapons are capable of causing severe or fatal injuries. In 2015, then Chairman of the Joint Chiefs of Staff General Martin Dempsey testified that hundreds of Americans had been killed by these devices. The terrorist attacks in question occurred in Iraq, but the court determined that the Islamic Republic of Iran provided material support or resources to those responsible for the attacks.

The families and estates of those injured or killed individuals first took legal action against Iran in March of 2019. Now, after more than three years, they have finally obtained the justice they deserve.

Attorney John J. Driscoll says of the judgment:

"We're very proud of the large judgment that we have obtained for our clients. Each one of them is a hero. Our clients and the family members that support them have given so much for our country. We are pleased that we could do something to help and honor them."

About The Driscoll Firm

The Driscoll Firm is a nationally recognized civil litigation firm with a strong track record of providing top-notch representation to military servicemembers, veterans, and their families. For more information about our firm, visit CampLeJeune.com or call us at (888) 209-0003.

SOURCE The Driscoll Firm


These press releases may also interest you

at 07:10
Aura Biosciences, Inc. , a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that data from the ongoing Phase 2 trial evaluating the safety...

at 07:10
Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Designtm platform for genetic medicine, today announced a strategic collaboration with Sanofi for the use of Scribe's CRISPR genome editing technologies to enable...

at 07:10
Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced interim results from the Type B portion of the...

at 07:10
Forge Biologics, a gene therapy-focused contract development and manufacturing organization, today announced the new availability of plasmid DNA manufacturing to its suite of scalable manufacturing services for gene therapy programs, complementing...

at 07:10
Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage biopharmaceutical company, announced today that enrollment for the Phase I clinical study of BAT2022 has been completed, showing that BAT2022 is well-tolerated and there were no DLT observed...

at 07:10
Labcorp , a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct. 27, 2022. The company will host a conference call and webcast beginning at 9 a.m. ET that day...



News published on 16 august 2022 at 11:50 and distributed by: